Presentation is loading. Please wait.

Presentation is loading. Please wait.

Budesonide Inhalation Suspension Versus Montelukast in Children Aged 2 to 4 Years with Mild Persistent Asthma  Stanley J. Szefler, MD, Lars-Goran Carlsson,

Similar presentations


Presentation on theme: "Budesonide Inhalation Suspension Versus Montelukast in Children Aged 2 to 4 Years with Mild Persistent Asthma  Stanley J. Szefler, MD, Lars-Goran Carlsson,"— Presentation transcript:

1 Budesonide Inhalation Suspension Versus Montelukast in Children Aged 2 to 4 Years with Mild Persistent Asthma  Stanley J. Szefler, MD, Lars-Goran Carlsson, MD, Tom Uryniak, MS, James W. Baker, MD  The Journal of Allergy and Clinical Immunology: In Practice  Volume 1, Issue 1, Pages (January 2013) DOI: /j.jaip Copyright © 2012 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2 Figure 1 Kaplan-Meier plot of time to first additional asthma medication (A) and first severe asthma exacerbation (B) requiring oral steroid therapy over the 52-week study period. The Journal of Allergy and Clinical Immunology: In Practice 2013 1, 58-64DOI: ( /j.jaip ) Copyright © 2012 American Academy of Allergy, Asthma & Immunology Terms and Conditions


Download ppt "Budesonide Inhalation Suspension Versus Montelukast in Children Aged 2 to 4 Years with Mild Persistent Asthma  Stanley J. Szefler, MD, Lars-Goran Carlsson,"

Similar presentations


Ads by Google